Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Antihypertensive Drugs: Angiotensin II Receptor Blockers

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...

Antihypertensive Drugs: Action of β1 Blockers

Antihypertensive Drugs: Action of β₁ Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...

Pathophysiology of Cardiac Performance

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...

Heart Failure II: Pathophysiology

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

Heart Failure Drugs: Diuretics

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

12-month outcomes of cavotricuspid isthmus ablation using a pentaspline pulsed field ablation catheter.

Heart rhythm·2026

Same author

Identification of immunomodulators associated with atrial fibrillation reporting to better understand AF immunologic mechanisms: a Vigibase retrospective disproportionality analysis and a literature review.

BMJ open·2026

Same author

Chlorhexidine vs Povidone-Iodine Alcohol Solutions for Cardiac Implantable Electronic Devices: A Prospective Randomized Study.

Journal of the American College of Cardiology·2026

Same author

Temporal trends in atrial fibrillation catheter ablation efficacy: A systematic review, meta-analysis and meta-regression from more than 20years of clinical data.

Archives of cardiovascular diseases·2025

Same author

Association Between the Renin-Angiotensin System and Ibrutinib-Related Cardiovascular Adverse Events: A Translational Cohort Study.

Biomedicines·2025

Same author

Redefining the anatomy of the triangle of Koch for the implantation of a dual-chamber single-capsule leadless pacemaker.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2025

Search research articles

Related Experiment Video

Updated: Jun 24, 2026

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

Effects of aldosterone on coronary function.

Ludovic Benard¹, Paul Milliez, Marie-Lory Ambroisine

¹INSERM U942 and University Paris-Diderot, Hospital Lariboisiere, Paris, France.

Pharmacological Reports : PR

|March 25, 2009

Summary

Aldosterone impacts cardiovascular health beyond its known roles, affecting non-epithelial tissues like the heart and blood vessels. Research shows it can decrease coronary reserve by impacting potassium channels.

More Related Videos

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Published on: June 28, 2019

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Published on: August 18, 2016

Related Experiment Videos

Last Updated: Jun 24, 2026

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Evaluation of Coronary Flow Reserve After Myocardial Ischemia Reperfusion in Rats

Published on: June 28, 2019

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Published on: August 18, 2016

Area of Science:

Cardiovascular Physiology
Endocrinology
Molecular Biology

Background:

Aldosterone's role in cardiovascular diseases is increasingly recognized, leading to the use of mineralocorticoid receptor (MR) antagonists.
Aldosterone primarily acts via MRs in epithelial cells to regulate sodium reabsorption.
Emerging evidence suggests aldosterone affects non-epithelial tissues and can act via non-genomic pathways.

Purpose of the Study:

To explore the multifaceted effects of aldosterone on cardiovascular tissues.
To investigate the mechanisms by which aldosterone influences cardiac function and vascular tone.
To clarify the role of aldosterone in non-epithelial tissues and potential non-genomic actions.

Main Methods:

Utilized diverse experimental models and transgenic mice to study cardiac aldosterone effects.
Investigated the impact of aldosterone on coronary reserve and specific ion channels (BKCa).
Examined aldosterone's direct effects on vascular cell relaxation mechanisms, including NO and EDHF pathways.

Main Results:

Aldosterone influences non-epithelial tissues, including the heart and blood vessels.
Increased cardiac aldosterone concentrations in mice led to decreased coronary reserve.
Aldosterone was found to decrease BKCa potassium channels in coronary smooth muscle cells, affecting vascular relaxation.

Conclusions:

Vascular cells are key targets of aldosterone in the cardiovascular system.
Aldosterone directly impacts nitric oxide (NO) and endothelium-derived hyperpolarizing factor (EDH)-mediated coronary relaxation.
These mechanisms contribute to the detrimental cardiovascular effects of mineralocorticoid receptor stimulation.